San Francisco, CANCT06716554Now EnrollingIRB Ready

Menopause Clinical Trial in San Francisco, CA

Access cutting-edge menopause treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by SF Research Institute, Inc.

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access menopause specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related menopause treatment provided free

Apply for This San Francisco Location

Check if you qualify for this menopause clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Menopause Study in San Francisco

This is a Multi-center, Multi-national, Prospective, Randomized, Double-Blind, Placebo- Controlled three arm study to evaluate the efficacy and safety of Shatavari for the treatment of Menopausal symptoms in Women. Participants will be randomized to either one of the three treatment arms.Participants will then be asked to either take one capsule containing Shatavari or Shatavari + Ashwagandha or Placebo orally once daily in the morning after breakfast with a glass of water for 8 weeks. All the subjects will be asked to continue their routine diet and physical activities during the whole study period. The primary objective is to compare the efficacy of shatavari for treatment of menopausal symptoms in women. The secondary objective is to compare the safety of shatavari for treatment of menopausal symptoms in women.

Sponsor: SF Research Institute, Inc.

Who Can Participate

Inclusion Criteria

Menopausal women aged 45 to 65 years with intact uterus and ovaries.
Participants who complained of irregular menstrual cycle in the past 12 months, with a forward or postpone of a cycle more 7 days. At least 2 cycles were missing during the past 12 months, or reported menopause for at least 60 days
Females with complaints of menopausal symptoms, e.g., hot flash, insomnia, migraine, easy irritation, etc.
Body mass index 18-35 kg/m2
Subject who has given written informed consent to participate in the study and understand the nature of the study
Able to read and write in English or any other vernacular language
No plan to commence new treatments over the study period.
Must have the ability and willingness to sign an informed consent and to comply with all study procedures.

Exclusion Criteria

Participants taking any form of herbal extract in the last 3 months before study entry.
Participants who are on hormone replacement therapy (HRT) for more than 3 months.
Participants with Present active medical, surgical, and gynaecological problems.
Participants with a history of alcohol, tobacco dependence, or any substance abuse
Participants who had undergone bilateral ovariectomy
Participants with history of breast or cervical carcinoma
Participants who taking medication that affect bone metabolism, including glucocorticoid, anticonvulsant, and methotrexate.
Participants with Clinically relevant cardiovascular, gastrointestinal, hepatic, neurologic, endocrine, haematologic or other major systemic diseases making implementation of the protocol or other interpretation of the study result difficult
Participants with mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study
Participants with evidence of uncooperative attitude, including poor compliance.
Participants with inability to attend follow-up visit
Participants with any other medical condition (for example uncontrolled infection) that may, in the opinion of the Investigator, interfere with the study objective.
Patients with known hypersensitivity to Ashwagandha.
Patients who had participated in other clinical trials during the previous 3 months.
Patients who have any clinical condition, according to the investigator who does not allow safe fulfilment of clinical trial protocol

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT06716554) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Menopause Treatment Options in San Francisco, CA

If you're searching for menopause treatment options in San Francisco, CA, this clinical trial (NCT06716554) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced menopause specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all menopause clinical trials near you to find additional studies recruiting in your area.

More Menopause Trials in San Francisco, CA

See all menopause clinical trials recruiting in San Francisco — not just this study.

Browse Menopause Trials in San Francisco →

Browse More Trials by Condition

Menopause TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA